Ascendio
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Ascendio is a Korean entertainment company that invests in, produces, and distributes films, develops and produces television dramas, and organises live performances and exhibitions.
Its content reaches audiences through broadcasters and other distribution channels. Listed on KOSPI, Korea's main stock exchange, the company has been expanding beyond its original film focus into dramas, variety entertainment, and live events, and is now also entering the textile and fabric business to diversify its revenue base.
Summary is AI-generated and may contain errors · figures from DART filings
Ascendio filed for court-supervised rehabilitation due to capital erosion and liquidity shortfalls, completing that process before restructuring around a content-focused business model.
Ascendio in five facts
What does Ascendio do?
Ascendio is a Korean entertainment company that invests in, produces, and distributes films, develops and produces television dramas, and organises live performances and exhibitions.
Where is Ascendio listed and in which sector?
Ascendio (Korean name: 아센디오) trades under KRX code 012170 on KOSPI, the main board of the Korea Exchange. It is classified in the Communication Services sector, Media.
How large is Ascendio?
Its market capitalisation was US$16M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Ascendio's latest annual revenue and operating profit?
For fiscal year 2025, Ascendio reported revenue of US$4.5M, an operating loss of US$3.3M and a net loss of US$10.4M, per its annual report on DART (data retrieved from DART on 2026-09-08). Revenue was down 56.0% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-08
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on securities held by executives/major shareholdersOct 21
- Report on large shareholdings (5% rule) (standard)Oct 21
- Report on large shareholdings (5% rule) (standard)Oct 21
- [Amended] Material event report (rights offering)
Ascendio updated the terms of a private placement (third-party allotment) to raise US$7.46M, about 40.8% of its market value.
Capital raise · Oct 14 · 4 versions - Results of rights offering or equity-linked bond issuance (voluntary)Capital raise · Oct 13
- [Amended] Material event report (equity acquisition)M&A · Oct 13 · 2 versions
- [Amended] Resolution to convene a general shareholders' meetingOct 12
- Notice of general shareholders' meetingOct 12
- [Amended] Resolution to convene a general shareholders' meetingOct 8
- Other market noticeOct 7
- Shareholder register closure / record date setSep 14
- Resolution to convene a general shareholders' meetingSep 14
- Supply contract signed
Ascendio disclosed a supply contract, worth US$1.19M, about 27.23% of its recent annual revenue, running through Sep 2027.
Supply contract · Sep 3 - Completion report on merger, etc. (asset transfer)
Ascendio completes its acquisition of land and buildings in Sindang-dong, Jung-gu, Seoul from Kyungnam Pharmaceutical for US$9.42M, settled through an in-kind third-party-allotment rights offering, with Kyungnam Pharmaceutical becoming Ascendio's largest shareholder at 44.50% after the transaction.
M&A · Aug 21 - Change of largest shareholder
Following payment for a third-party-allotment rights offering, Ascendio Co., Ltd.'s largest shareholder changed from Kiwi No.1 Partnership (46.30%) to Gyeongnam Pharmaceutical Co., Ltd. and 1 other (70.20%) on August 10, 2026, with the 3,246,683 newly acquired shares subject to a 1-year lock-up.
Ownership change · Aug 10 - Results of rights offering or equity-linked bond issuance (voluntary)
Ascendio Co., Ltd. completed a third-party allotment rights offering of 3,246,683 common shares for US$9.24M, paid via court-approved contribution in kind on August 10, 2026, with the new shares subject to a full 1-year lock-up and listing expected September 1, 2026.
Capital raise · Aug 10 - [Amended] Material event report (rights offering)
Ascendio updated the terms of a private placement (third-party allotment) to raise US$9.22M, about 60.5% of its market value.
Capital raise · Jul 31 · 2 versions - Results of rights offering or equity-linked bond issuance (voluntary)Capital raise · May 18
- Material event report (rights offering)
Ascendio disclosed a private placement (third-party allotment) to raise US$687K, about 4.6% of its market value.
Capital raise · May 8 - Supply contract signed
Ascendio disclosed a supply contract with Zip Cinema Co., Ltd., worth US$2.04M, about 50.93% of its recent annual revenue, running through Apr 2027.
Supply contract · Apr 13 - [Amended] Material event report (convertible bonds)
Ascendio updated the terms of convertible bonds to raise US$7.01M, about 46.1% of its market value.
Capital raise · Feb 26 - [Amended] Material event report (convertible bonds)
Ascendio updated the terms of convertible bonds to raise US$4.2M, about 27.7% of its market value.
Capital raise · Feb 26 - [Amended] Material event report (convertible bonds)
Ascendio updated the terms of convertible bonds to raise US$4.2M, about 27.7% of its market value.
Capital raise · Feb 26 - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Ascendio updated its previously filed consolidated results for FY2025: revenue of US$4.05M (−56.27% year on year), an operating loss of US$2.97M and a net loss of US$8.48M.
Earnings · Feb 11 · 2 versions - Change of largest shareholderOwnership change · Jan 16
- Results of rights offering or equity-linked bond issuance (voluntary)Capital raise · Jan 16
- [Amended] Material event report (rights offering)Capital raise · Jan 15